HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PSO-TOP study group Selected Research

Elements

7/2017A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


PSO-TOP study group Research Topics

Disease

1Psoriasis (Pustulosis Palmaris et Plantaris)
07/2017

Drug/Important Bio-Agent (IBA)

1betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric
07/2017
1calcipotriene (calcipotriol)FDA LinkGeneric
07/2017
1Betamethasone (Celestone)FDA Link
07/2017
1ElementsIBA
07/2017

Therapy/Procedure

1Therapeutics
07/2017